Home
overview
Licensing is playing an increasing role in the business model of pharmaceutical and biotechnology companies. In 2003, 24.4% of the sales of the top 20 pharmaceutical companies were derived from in-licensed drugs. In response, licensing has moved away from its roots as a transaction for intellectual property rights, emerging as a key value driver. Industry leaders now recognise licensing as a strategic mechanism through which they can achieve their corporate objectives

SMi's 3rd Annual Collaborations and Licensing in the Pharma & Biotech Industries Conference will provide attendees with an overview of the market including strategic partnerships in biotechnology supported by an analysis of recent deal case studies. The conference aims to cover topical issues including the CRO/Pharma collaborations - what can pharma companies learn from CROs? Out-licensing activities of big pharma companies - what is for sale? How venture capitalist knowledge systems are used to assist the licensing process and their role in bringing new drugs to market.

"A must attend event complete with leading industry experts in the field discussing the latest tools and ideas to enhance your deal-making process"

Gain an insight from the key industry leaders in the field including:

Dr Ray Hill, Executive Director, Licensing & External Research, Merck
Dr Mark Rogers, Director, Licensing & Development, Pfizer
Dr Jürgen Heitmann, Senior Manager, Out-Licensing & Partnering, Novartis
Associate Professor Brita Sjöström, Vice President, Contract Sales, Biovitrum
Dr Dee Athwal, Director, Business Development, UCB-Celltech Group
Andrew Mackie, Head, Alliance Management, Antisoma
Anthony Nagle, Managing Director - Region Europe, Fuld & Company
Joel Besse, Senior Partner, Atlas Venture
Dr Stephen Barnhill, Chairman & Chief Executive Officer, Health Discovery Corporation

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Mark Rogers

Mark Rogers, Director, Licensing & Development, Pfizer

9:10 GETTING THE MOST OUT OF THE COLLABORATION

Gregory  Berman

Gregory Berman, Medical Products Group Leader, PA Consulting

  • Optimising research and development
  • Speed of delivery
  • Benefits and opportunities for better partnerships
  • Moving towards strategic relationships
  • 9:50 TRENDS IN DEAL-MAKING

    Anthony Nagle

    Anthony Nagle, Managing Director - Region Europe , Fuld & Co

  • Where is your competitive advantage?
  • Application to in-licensing
  • Application to out-licensing
  • Saving time and money
  • 10:30 Morning Coffee

    11:00 COLLABORATIONS AND LICENSING

    Andrew Mackie

    Andrew Mackie, Head, Alliance Management, Antisoma

  • In-licensing from universities
  • Out-licensing to big pharma
  • Structuring the relationships to maximise the benefit for both sides
  • Antisoma - Roche relationship: lessons learnt
  • 11:40 CONTRACT MANUFACTURING RELATIONSHIPS

    Brita Sjöström

    Brita Sjöström, Vice President, Contract Sales, Biopharmaceuticals, Biovitrum AB

  • Managing contract manufacturing
  • Communication - a key success factor
  • Agree on timelines
  • Defining results and deliverables
  • 12:20 Networking Lunch

    14:00 IN-LICENSING AND BIOTECH PARTNERSHIPS

    Loïc  Kubitza

    Loïc Kubitza, Assistant Director, Valuation & Strategy, PricewaterhouseCoopers

  • Recent trendsin biotech alliances
  • Estimating the value of licensnig deals
  • The limitations of licensing for biotech emancipation
  • 14:40 OUT-LICENSING ACTIVITES OF BIG PHARMA COMPANIES

    Jürgen Heitmann

    Jürgen Heitmann, Senior Manager, Out-Licensing & Partnering, Novartis

  • Why do the key players license-out?
  • What kinds of opportunities exist?
  • How to get them
  • Typical deal constructs
  • 15:20 THE BENEFITS AND RISKS ASSOCIATED WITH GLOBAL PRODUCT LICENSING

    Mark Rogers

    Mark Rogers, Director, Licensing & Development, Pfizer

  • What are the benefits and issues associated with global product licensing?
  • Assessing the technology/commercial and business risk of global product licensing candidates
  • What are the critical success factors and future directions for global product licensing?
  • 16:00 Afternoon Tea

    16:00 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Anthony Nagle

    Anthony Nagle, Managing Director - Region Europe , Fuld & Co

    9:10 VENTURE CAPITALIST KNOWLEDGE SYSTEMS

    Joel Besse

    Joel Besse, Senior Partner, Atlas Venture

  • What is their role in bringing new drugs to market?
  • Are they more effective innovators?
  • Driving shareholder value
  • Attracting investors
  • Improving valuation
  • CRM systems
  • 9:50 THE USE OF MERGERS AND ACQUISITIONS TO BOLSTER PRODUCT PIPELINES

    Dee Athwal

    Dee Athwal, Director, Business Development, UCB-Celltech

  • Building a global integrated biopharma business
  • Combining small molecule expertise with biologicals
  • Challenges
  • UCB acquisition of Celltech
  • 10:30 Morning Coffee

    11:40 CRO/PHARMA COLLABORATIONS

    Doug Cookson

    Doug Cookson, Marketing Manager, Quintiles (UK) Ltd

  • Facilitating an effective relationship
  • What are the risks and benefits?
  • What can pharma companies learn from CROs?
  • Challenges and limitations
  • 12:20 Networking Lunch

    14:00 RECENT DEAL CASE STUDY

    Chris Neild

    Chris Neild, Director, Strategy & Commercial Services, Bridgehead International

  • How do deal values change through the late stages of development?
  • Case studies
  • How significant is the trend to late stage profit-sharing?
  • Is late stage profit-sharing sustainable?
  • 14:40 EVOLUTION OF THE MERCK APPROACH TO LICENSING

    Ray Hill

    Ray Hill, Executive Director, Licensing & External Research, Merck

  • Important aspects of organisation
  • How to locate and manage opportunities
  • Recent case histories
  • 15:20 WHAT MAKES A SUCCESSFUL BUSINESS DEVELOPMENT PROFESSIONAL

    Ann Gales

    Ann Gales, Director, International Search, Ruston Poole International

  • What the client wants
  • Different organisations/different roles
  • Business development as part of the executive/management team
  • International perspective
  • 16:00 Afternoon Tea

    16:00 Chairman’s Closing Remarks and Close of Day One

    +

    Radisson Edwardian Marlborough Hotel

    9-13 Bloomsbury Street
    London WC1B 3QD
    United Kingdom

    Radisson Edwardian Marlborough Hotel

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.